Circadin(R), A Novel First In Class Insomnia Medication Now Available In Poland, Hungary And Czech Republic

Lundbeck has entered the sleep disorder market in Eastern Europe with three consecutive launches of first in class insomnia medication, Circadin® in Poland, Hungary and Czech Republic. Circadin®, a sustained-release melatonin, is indicated as monotherapy for the short-term treatment of primary insomnia in patients who are aged 55 or over.

More: continued here

Filed under: Sleep / Sleep Disorders on October 27th, 2008